CRP and non-small cell lung carcinoma: Moreover, besides disease-related factors, CRPcycle3 and CRPcycle3-2 were stronger prognostic factors compared with baseline CRP concentrations to identify patients with advanced NSCLC at earlier risk of progression and/or death, for timely decision-making and therapy optimization.